| [1] |
DIAO Ziyue, XIA Ruiyuan, YIN Zhiqiang.
Update of targeted therapy for localized pustular psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 456-460.
|
| [2] |
HUAI Pengcheng, CHU Tongsheng, LIU Dianchang, LIU Jian, ZHANG Furen.
Analysis of leprosy symptomatic surveillance in Shandong Province in 2021
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 313-315.
|
| [3] |
SANG Xu, WANG Zhenzhen, LI Wenchao, LIU Hong, ZHANG Furen.
Cost-effectiveness analysis of biologic agents in the treatment of moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 344-349.
|
| [4] |
LIU Jun, ZHANG Xianling, CAO Wenfa, SUN Chuanzhi, HU Fengchan.
Epidemiological analysis of leprosy new cases in Shaanxi Province from 2011 to 2020
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 350-352.
|
| [5] |
CAO Shan, SUN Yonghu, ZHAO Qing, LIU Hong, ZHANG Furen.
IL-17 inhibitor treated a specific type of psoriasis resistant to TNF-α inhibitor
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 353-354.
|
| [6] |
HUAI Pengcheng, WANG Zhenzhen, KONG Yaoyao, CHU Tongsheng, LIU Dianchang, LI Congcong, YAO Mengyuan, LI Hongda, JIN Chuanyang, YUAN Zhaojun, LIU Mengmeng, LI Wenchao, LIU Hong, LIU Jian, ZHANG Furen.
Optimizing a predictive model of leprosy in the Chinese population based on genetic and epidemiological risk factors
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(4): 225-230.
|
| [7] |
SUN Lijiao, FENG Shumei, WU Shan, ZHANG Hongmao.
Epidemiological characteristics of the spatial distribution of new leprosy cases in Gansu Province from 2000 to 2020
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(4): 253-256.
|
| [8] |
XU Kun, WEI Jin, XIE Hongqiang, GU Jiaxu, ZHANG Guocheng.
Investigation on the awareness of early symptoms and prevention knowledge of leprosy among medical students
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(4): 257-260.
|
| [9] |
SHI Linli, YAN Shaochen, BI Xinling.
Update of paradoxical reactions induced by commonly used biological agents in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 201-205.
|
| [10] |
LIU Jian, ZHANG Zhiqin, YIN Zhiqiang.
Update of relationship between regulated cell death and psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 206-211.
|
| [11] |
LU Zixuan, WU Jianhua.
Update of extracellular vesicles in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 218-222.
|
| [12] |
CHU Tongsheng, LIU Dianchang, HUAI Pengcheng, LIU Jian, ZHANG Furen.
Assessment of leprosy registered active cases management measures in Shandong Province during 2011-2020
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 73-76.
|
| [13] |
LI Ge, ZHANG Yuchen, SONG Yunlong, ZHANG Hong, WANG Yaofei, WANG Guan.
Clinical and epidemiological characteristics of elderly leprosy patients in low prevalence of leprosy
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 82-85.
|
| [14] |
LONG Heng, YIN Lijiao, ZHANG Chunyu, YU Xiufeng, SHEN Lianfa, SU Youfeng.
Effect of physical examination among blood relatives of leper in early detection of leprosy
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 89-92.
|
| [15] |
WANG Qian, LI Yong, WANG Yiyi, LIU Hongjie, LI Wei.
Pulsed dye laserombined with calcipotriol betamethasone cream in the treatment of nail psoriasis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 93-98.
|
